BioAtla, Inc. (BCAB) vs Onconetix, Inc. (ONCO)
- BioAtla, Inc. BCAB 1.36 +4.62%
- Onconetix, Inc. ONCO 0.48 −12.73%
BioAtla, Inc. and Onconetix, Inc. are both Biotechnology companies. BioAtla, Inc. and Onconetix, Inc. are of similar size ($2.9M and $2.9M). BioAtla, Inc. has negative trailing earnings, so its P/E is not meaningful; Onconetix, Inc. trades at 0.0×. BioAtla, Inc. grew revenue faster over the last twelve months: 574.7% against −51.3%. BioAtla, Inc. has the higher net margin (−177.2% vs −1,578.6%) and the higher return on invested capital (0.00% vs −135.4%). Across the 15 metrics below, BioAtla, Inc. leads on 9 and Onconetix, Inc. on 6.
Valuation
Profitability
| Metric | BCAB | ONCO | Biotechnology median |
|---|---|---|---|
| Gross margin | 95.44% | 80.38% | 65.16% |
| Operating margin | (180.99%) | (2,524.73%) | 0.00% |
| Net margin | (177.21%) | (1,578.60%) | 0.00% |
| Free cash flow margin | (132.29%) | (1,595.90%) | 0.00% |
| Return on equity | 118.74% | (105.23%) | (56.36%) |
| Return on assets | (171.72%) | (57.37%) | (48.04%) |
| Return on invested capital | 0.00% | (135.42%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack